GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BML Inc (OTCPK:BMLKF) » Definitions » Price-to-Owner-Earnings

BML (BMLKF) Price-to-Owner-Earnings : (As of May. 22, 2024)


View and export this data going back to 2009. Start your Free Trial

What is BML Price-to-Owner-Earnings?

As of today (2024-05-22), BML's share price is $12.675. BML does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for BML's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of BML was 152.47. The lowest was 28.71. And the median was 42.26.


BMLKF's Price-to-Owner-Earnings is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 25.11
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-05-22), BML's share price is $12.675. BML's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $1.07. Therefore, BML's PE Ratio for today is 11.88.

As of today (2024-05-22), BML's share price is $12.675. BML's EPS without NRI for the trailing twelve months (TTM) ended in was $1.08. Therefore, BML's PE Ratio without NRI for today is 11.77.

During the past 13 years, BML's highest PE Ratio without NRI was 32.08. The lowest was 3.68. And the median was 16.75.


BML Price-to-Owner-Earnings Historical Data

The historical data trend for BML's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BML Price-to-Owner-Earnings Chart

BML Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BML Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BML's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, BML's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BML's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BML's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where BML's Price-to-Owner-Earnings falls into.



BML Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

BML's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=12.675/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BML  (OTCPK:BMLKF) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


BML Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of BML's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


BML (BMLKF) Business Description

Traded in Other Exchanges
Address
5-21-3 Sendagaya, Shibuya-ku, Tokyo, JPN, 1510051
BML Inc provides laboratory testing services in Japan through a network of regional facilities. Its core clinical testing business provides a range of general and specialty laboratory tests, as well as microbiological tests that can be used for applications like food sanitation and environmental analysis. BML often uses automated systems to process and analyze these test samples. In addition to its clinical testing business, BML also has a medical information systems business and a genome-related business. The medical information systems business provides electronic medical charts and information systems that can be used in conjunction with its laboratory tests. The genome business provides gene analysis services.